Articles reporting survival by Ki-67 using a cut-off of 5% and 20%
| Author | Patient demographic | Ki-67 notes | ||
|---|---|---|---|---|
| Ki-67 labelling index (%) | 5-Year survival (%) | No. | ||
| Martin-Perez et al28 | 481 consecutive patients, (184 stained), pancreatic neuroendocrine tumours (NETs) and peripancreatic NETs. Surgical resection and biopsy | ≤5 | 85.7 | 118 |
| >5–20 | 46.3 | 46 | ||
| >20 | 17.4 | 20 | ||
| Bertani et al29 | 110 consecutive patients (41 patients stained) primary NET with unresectable liver metastases. Surgical resection only | ≤5 >5–20 | 90 58 | 10 21 |
| >20 | 20 | 10 | ||
| Scarpa et al20 | 274 consecutive patients (237 patients stained) Pancreatic endocrine tumours operated on. Surgical resection and biopsy | ≤5 | 91 | 166 |
| >5–20 | 52 | 93 | ||
| >20 | 12 | 30 | ||
| Hentic et al21 | 45 consecutive patients, metastatic digestive endocrine carcinoma. All with liver metastases. Surgical resection and biopsy | ≤5 | 95 | 19 |
| >5–20 | 52 | 23 | ||
| >20 | 33 | 3 | ||